Most recent by Adrienne H. Tam, PharmD, BCPS
SPONSORED CONTENT
January 25, 2011
5 min read
Save
Cabazitaxel: Just another taxane for prostate cancer?
The year 2010 was an encouraging time for prostate cancer patients, as significant strides in research led to the FDA approval of two new agents, sipuleucel-T and cabazitaxel.